KRAS and colorectal carcinoma: Recently, Sajida et al. has reported that the expression of the Ca2+ activated potassium channel KCNN4 (SK4) is significantly enhanced in CRC tissues in comparison with the normal tissues, and KCNN4 expression is much higher in patients with KRAS-positive mutations than wild-type patients 45.